July 28, 2014 7:42 PM ET

Oil, Gas and Consumable Fuels

Company Overview of Verenium Corporation

Executive Profile

Melvin I. Simon Ph.D.

Senior Advisor, Annai Systems Inc.
AgeTotal Calculated CompensationThis person is connected to 1 Board Members in 1 different organizations across 3 different industries.

See Board Relationships
76--

Background

Dr. Melvin I. Simon, Ph.D., also known as Mel, serves as Scientific Advisor of Verenium Corporation (formerly Diversa Corp.) and served as its Resident Scientific Advisor until December 31, 2004. Dr. Simon serves as Senior Advisor of Annai Systems Inc. He has made important contributions to many areas of bacterial and human molecular genetics, including the Human Genome Project. He was the Founder of Agouron Pharmaceuticals, Inc. He was the Chairman and Professor in ...

Corporate Headquarters

3550 John Hopkins Court
San Diego, California 92121

United States

Phone: 858-431-8500
Fax: --

Board Members Memberships

1984-N/A
Former Director
1994-2008
Scientific Advisor

Education

PhD
Brandeis University
BS
The City College of New York

Other Affiliations

Annual Compensation

There is no Annual Compensation data available.

Stocks Options

There is no Stock Options data available.

Total Compensation

There is no Total Compensation data available.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

COMPETITOR COMPENSATION

There is no Competitor Compensation data available.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact Verenium Corporation, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.